Accueil > Actualité
Actualite financiere : Actualite bourse

GE Healthcare: UBS now a seller

(CercleFinance.com) - The analyst downgrades his opinion on the stock to Sell (from Neutral), with a target price cut to E74 (from E84) - pmt: $91.
5, -1.5%), which represents 20% downside potential.

UBS believes that earnings are taken into account but risks are not.

GE Healthcare's medium-term margin forecasts are exaggerated and the risks relating to China are significant. Forecasts are reduced to 3%-6% below consensus, UBS says.

GE Healthcare has confirmed its annual adjusted EPS target range of $4.20-$4.35, and has raised adjusted EBIT margin forecast to 15.7%-16%, but has reduced organic revenue growth expectations to +1%-2%, 'due to headwinds in China'.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.